Session Details

[27-16-pm]Disease Treatment DDS, Gene DDS

Thu. Mar 27, 2025 1:15 PM - 2:51 PM JST
Thu. Mar 27, 2025 4:15 AM - 5:51 AM UTC
Room 16 (MARINE MESSE FUKUOKA Hall B: Conference Room1-2 [2F])
Chair: Makoto Shirakawa, Hidefumi Mukai

[27-16-pm01S]Novel preparation of doxorubicin bound carboxyhemoglobin-albumin clusters using fatty acid binding sites in human serum albumin

○Chihiro Ito1, Kazuaki Taguchi1, Taiga Yamada2, Kengo Hanaya1, Yuki Enoki1, Teruyuki Komatsu2, Kazuaki Matsumoto1 (1. Keio Univ., Fac. Pharm., Grad. Sch. Pharm. Sci., 2. Chuo Univ., Fac. Sci. and Eng.)

[27-16-pm02S]Development of improved oncolytic adenovirus based on human adenovirus serotype 35

○Miu Hayashi1, Ryosuke Ono1, Masashi Tachibana1,2, Fuminori Sakurai1,3, Kahori Shimizu1, Noriyuki Kijima4, Hiroyuki Mizuguchi1,5,6,7,8 (1. Grad. Sch. Pharm. Sci., Osaka Univ., 2. Col Life Sci, Ritsumeikan Univ, 3. Dept. Pharm., Kindai Univ., 4. Grad. Sch. Med., Osaka Univ., 5. Natl. Inst. Biomed. Innov. Health Nutr., 6. Cent. Med. Engi. Info., Osaka Univ., 7. Inte. Fron. Rese. Med. Sci. Div., Inst. Tran. Rese. Init., Osaka Univ., 8. Cent. Infe. Dis. Edu. Rese., Osaka Univ.)

[27-16-pm03S]Development of PIC nanosystem as a platform to integrate oligonucleotides and proteins for vaccine applications

○Sooyeon Lee1, Bing Jhang Li1, Hiroshi Kamizawa1, Teruki Nii1,2, Takeshi Mori1,2,3, Yoshiki Katayama1,2,3,4,5, Akihiro Kishimura1,2,3,4 (1. Graduate School of System Life Sciences, Kyushu University, 2. Department of Applied Chemistry, Faculty of Engineering, Kyushu University, 3. Center for Future Chemistry, Kyushu University, 4. Center of Molecular Systems (CMS), Kyushu University, 5. Center of Advanced Medical Open Innovation, Kyushu University)

[27-16-pm04S]Regulation of the blood-brain barrier and promotion of brain drug delivery using Claudin-5-binding small molecules

○Atsuya Shirono1, Saito Inoue1, Yoshiki Ikeda2, Jumpei Taguchi3, Satomi Tomita3, Hitomi Tabuchi3, Takamitsu Hosoya3, Hiroyuki Takeda4, Masuo Kondoh1,5, Yasushi Fujio1,5, Yoshiaki Okada1,5 (1. Grad. Sch. Pharm. Sci., Osaka Univ., 2. iCeMS, Kyoto Univ., 3. LBB, IIR, Institute of Science Tokyo, 4. PROS, Ehime Univ., 5. Center for Infectious Disease Education and Research (CiDER), Osaka Univ.)

[27-16-pm05S]Pharmacokinetic analysis of the protein-bound cisplatin in intravenous injection and evaluation of its impact on adverse and antitumor effects

○Cristina Nana Amorim Matsuo1, Hidenori Ando1,2, Haruka Takata1,2, Tatsuhiro Ishida1,2 (1. Pharm. Sci., Tokushima Univ., 2. iDDS, Tokushima Univ.)

[27-16-pm06]Establishment and Comparison of Two Novel Methods for Adenoviral Vector Construction

○Maimu Rikitake1,2, Hidesato Ogawa1, Shimon Goto1, Fuminori Sakurai2,3, Hiroyuki Mizuguchi2,4,5,6,7 (1. BIKEN, 2. Grad. Sch. Pharm. Sci., Osaka Univ., 3. Sch. Pharm. Sci., Kinki Univ., 4. NIBIOHN, 5. MEI, Osaka Univ., 6. OTRI, Osaka Univ., 7. CiDER, Osaka Univ.)

[27-16-pm07]Investigation of helper lipid components to improve mRNA-LNP vaccine

○Tatsuya Karaki1,2, Yoshino Kawaguchi1, Taro Shimizu1,3,4, Toshiro Hirai1,3,4,5, Yasuo Yoshioka1,2,3,4,5,6,7 (1. RIMD, Osaka Univ., 2. BIKEN, 3. OTRI, Osaka Univ., 4. CAMaD, Osaka Univ., 5. Grad. Sch. Pharm. Sci., Osaka Univ., 6. MEI, Osaka Univ., 7. CiDER, Osaka Univ.)

[27-16-pm08S]Evaluation of distribution mechanisms of lipid nanoparticles to peritoneal dissemination via i.p. administration.

○Chongjie Zhang1, Yui Matsumoto1, Yutaro Chino1, Yuta Tamemoto1, Hiroto Hatakeyama1 (1. Grad. Sch. Pharm. Sci., Chiba Univ.)